Dr. David C. Shyr

Claim this profile

Stanford Children's Hospital

Studies Acute Lymphoblastic Leukemia
Studies Biphenotypic Leukemia
3 reported clinical trials
4 drugs studied

Area of expertise

1

Acute Lymphoblastic Leukemia

David C. Shyr has run 2 trials for Acute Lymphoblastic Leukemia. Some of their research focus areas include:

Stage II
Stage I
2

Biphenotypic Leukemia

David C. Shyr has run 1 trial for Biphenotypic Leukemia. Some of their research focus areas include:

Stage II
Stage I

Affiliated Hospitals

Image of trial facility.

Stanford Children's Hospital

Image of trial facility.

Lucile Packard Children's Hospital Stanford University

More about David C. Shyr

Clinical Trial Related

2 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 0 Active Clinical Trials

Treatments David C. Shyr has experience with

  • Haploidentical Hematopoietic Cell Transplantation (haploHCT)
  • Matched Unrelated Donor Hematopoietic Cell Transplantation (MUD-HCT)
  • Nomacopan (rVA576)
  • CTL019

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does David C. Shyr specialize in?

Is David C. Shyr currently recruiting for clinical trials?

Are there any treatments that David C. Shyr has studied deeply?

What is the best way to schedule an appointment with David C. Shyr?

What is the office address of David C. Shyr?

Is there any support for travel costs?